🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a robust trade exists on Telegram, where groups with thousands of members share comparison images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of uncertain source.

Several professionals stated the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the British medical regulations.

Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer laws, risking fines, prosecution or prison.

Service Reaction and Material Elimination

Based on TikTok, the platform has taken down problematic content and banned associated keywords and query recommendations. The organization stated it was committed to maintaining the service safe and investing in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or administering at home.

After moments of entering one group, a vendor shared WhatsApp details, where most transactions take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Product Information and Pricing

Inside these groups, messages display black plastic packages with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20mg. When asked how much time a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Although the science behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her staff has previously encountered individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to potentially serious health risks”.